Clinical Trial Details

Overview

Research Study Summary

Have You Been Diagnosed with Systemic Lupus Erythematosus-SLE? Research Study DV7-SLE-02

Purpose

Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent.

If you have SLE, you may be eligible to participate in this important clinical research study. You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required.

Compensation for time and travel up to $1,375.00. This is a phase 1 study requiring multiple injections, blood draws, assessments and visits to the site.

To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

Patient Inclusion Criteria:
You may qualify to participate if you:

  • Are at least 18 years old
  • Have a confirmed diagnosis of Systemic Lupus Erythematosus

Patient Exclusion Criteria:

  • If you do not have a confirmed diagnosis of Systemic Lupus Erythematosus.

To Learn more

CW ID: 181927
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Phase
1
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A
Compensation
Up to $1,375

Contact

Metroplex Clinical Research Center
8144 Walnut Hill Lane Suite 810
Dallas, TX 75231
Phone: 214-424-0405

View Map

Research Center Information: Metroplex Clinical Research Center

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.